Therapeutic strategy in the management of stage II - IV epithelial ovarian carcinoma

Chinese Medical Journal

Volumn 113, Issue 7, 2000, Pages 625-627

  Sun, T ^a   Feng, Y ^a   Zhu, Y ^a   Zheng, Y ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Epithelial ovarian carcinoma; Management strategy

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0033860551     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Neoadjuvant chemotherapy for ovarian cancer
2. Medical statistics. Analysis of follow-up data
3. Primary cytoreductive surgery for epithelial ovarian cancer
4. Treatment of stage III and stage IV ovarian cancer - Is neoadjuvant chemotherapy effective?
5. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer
6. Short-term effects of chemotherapy-surgery-chemotherapy regimen on clinically inoperable advanced ovarian cancer
7. Evaluation of second cytoreductive surgery in the treatment of epithelial ovarian cancer
8. Second cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: A gynecologic oncology group study